Advances in Assessing & Treating Severe Hypoglycemia In Practice
Severe Hypoglycemia is Still a Serious & Significant Problem in Both Type 1 & Type 2 Diabetes
An Online Enduring CME Activity – 1.0 CEUs
HOW LOW IS LOW?
Severe Hypoglycemia is still a serious and significant problem in persons with type 1 and type 2 diabetes treated with sulfonylureas and/or insulin. Providers can help to identify, prevent and address this problem by assessing patients at risk. Avoidance is the first step and being prepared with the best rescue therapies is essential for rapid recovery. We’re taking a deep dive into what you need to know to address hypos in your patients with diabetes.
“These are ABSOLUTELY the best speakers on the topic.”
After Completing this Activity, Participants Should be Able to:
1. Describe the clinical, emotional and public health significance of Severe Hypoglycemia in persons with T1D and T2D treated with sulfonylureas and or insulin.
2. Assess patients at risk for Severe Hypoglycemia and discuss recognition and treatment strategies that address individual treatment barriers.
3. Implement a care and education plan for providers to educate their patients about Severe Hypoglycemia using a glucagon option appropriate for them and to ensure each patient has an unexpired glucagon kit at home.
This course is designed for diabetes healthcare providers including endocrinologists, primary care physicians, nurse practitioners, physician assistants, nurses, certified diabetes educators, pharmacists, and other healthcare providers wanting to expand their knowledge of diabetes management.
*STEVEN V. EDELMAN, MD
Founder & Director, TCOYD; Endocrinologist, Clinical Professor of Medicine, University of California, San Diego (UCSD) School of Medicine; Director, Diabetes Care Clinic, VA Medical Center San Diego
Dr. Edelman is a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego. Dr. Edelman, who has type 1 diabetes himself, has written more than 200 articles, five books, and has won numerous awards for teaching and humanitarianism. He has been chosen by the medical students at UCSD as the ‘teacher of the year’ numerous times. Among his many honors, Dr. Edelman has received the ‘Diabetes Educator Of The Year’ award by the American Diabetes Association, the ‘Distinction in Endocrinology’ award by the American Association of Clinical Endocrinologists, and named ‘Top 1% of U.S. Endocrinologists’ by US News and World Report.
*JEREMY PETTUS, MD
Type 1 Track & Professional Education Director, Endocrinologist, Associate Professor of Medicine, UCSD School of Medicine
Dr. Jeremy Pettus was diagnosed with type 1 diabetes when he was 15 years old. Since that time he has dedicated his career to educating and treating others like himself. He is currently an Endocrinologist and Associate Professor of Medicine at the University of California, San Diego. There, he focuses primarily on clinical trials to develop and test new and innovative therapies for people living with diabetes. These include studies ranging from medications to reverse or slow the disease once it occurs, to islet cell transplantation strategies, to device studies such as artificial pancreas technology. As somebody who has the disease himself, sees patients with type 1, and is actively working on curing/treating the disease, we are honored to have him at TCOYD.
WILLIAM POLONSKY, PhD, CDCES
Clinical Psychologist; Founder & CEO, Behavioral Diabetes Institute
Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, the world's first organization totally dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also Associate Clinical Professor in Psychiatry at the University of California, San Diego. Dr. Polonsky received his PhD in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators. A licensed clinical psychologist and certified diabetes educator, he received the American Diabetes Association’s 2014 Richard R. Rubin Award for distinguished contributions to behavioral medicine and psychology.
This activity is jointly provided by Global Education Group and Taking Control Of Your Diabetes.
This activity is supported by an educational grant from Xeris Pharmaceuticals and Zealand Pharma.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Taking Control of Your Diabetes. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-22-039-H01-P)
This is a knowledge-based activity.
Dietitian Accreditation Statement
Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activities / materials. CPE Provider #GE012
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Taking Control of Your Diabetes. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.0 hour(s) of pharmacology).
Certified Diabetes Educator Accreditation Statement
This program is joint provided with the Association of Diabetes Care & Education Specialists, an approved provider on the CBDCE list of Approved Providers.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must pass the posttest with at least 70%. They must also complete the activity evaluation and submit it. Certificates can be downloaded at completion and a copy is also emailed immediately (check your spam folder).
Fee Information & Refund/Cancellation Policy
This is a complimentary educational activity. You may cancel your registration at any time prior to the event. Contact Sarah Severance at email@example.com with any questions or concerns.
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
|Name of Faculty or Presenter||Reported Financial Relationship|
|Steven V. Edelman, MD||Advisor: AstraZeneca, BrightSight, InPen, Lexicon, Lilly USA, LLC, MannKind Corporation, Merck, Sanofi-aventis U.S. Inc.
Consultant: Senseonics, Team Type 1
Speaker’s Bureau: AstraZeneca, Lilly USA, LLC, MannKind Corporation, Merck, Sanofi-aventis U.S. Inc.
|Jeremy Pettus, MD||Consultant: Diasome, Novo Nordisk, Sanofi-aventis U.S. Inc., Zealand Pharma
Speaker’s Bureau: MannKind Corporation
|William H. Polonsky, PhD, CDCES||Consultant: Abbott Laboratories, BigFoot, Boehringer Ingelheim, Dexcom, Eli Lilly, Insulet, Intuity, MannKind, Novo Nordisk, Sanofi-aventis U.S. Inc.
Researcher: Abbott Laboratories, Dexcom
The planners and managers have the following relevant financial relationships with ineligible companies:
|Name of Planner or Manager||Reported Financial Relationship|
|Rhys Williams, MSN, FNP-C, RN||Nothing to disclose|
|Amanda Turner MS, RDN, CSSD||Nothing to disclose|
|Lindsay Borvansky||Nothing to disclose|
|Andrea Funk||Nothing to disclose|
|Liddy Knight||Nothing to disclose|
|Ashley Cann||Nothing to disclose|
|Kim Rodriguez||Nothing to disclose|
|Sarah Severance||Nothing to disclose|
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Taking Control of Your Diabetes do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.